空间基因表达造型揭示了NF1-关联的外围神经膜瘤进展的免疫瘤性程序
Dana K Mitchell1, Breanne Burgess2,3, Emily E White2,4
1Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana.
概括
研究人员在神经纤维瘤中发现了早期的分子特征,这些特征预测了神经纤维瘤类型1 (NF1) 中的恶性转变. 这些发现可能会导致用于识别高风险状神经纤维瘤 (PNF) 的诊断工具.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
背景情况:
- Plexiform 神经纤维瘤 (PNF) 是神经纤维瘤类型 1 (NF1) 中的良性瘤.
- 一个PNFs子集进展到恶性外围神经膜瘤 (MPNST),这是NF1.1的主要死亡原因.
- 恶性转变往往由非典型神经纤维瘤 (ANF) 病变先发,但早期的转录性变化不太了解.
研究的目的:
- 在NF1.1.中定义神经纤维瘤到MPNST频谱中的基因表达特征.
- 识别与PNF进化和恶性转变相关的早期分子特征.
主要方法:
- 从NF1患者和小鼠模型中分析PNST中的基因表达特征.
- 研究了神经纤维瘤,非典型神经纤维瘤和MPNST中的转录变化.
- 针对MPNST细胞系和前体中的CENPF和BIRC5等关键介质.
主要成果:
- 非典型的神经纤维瘤显示增强的抗原呈现和免疫反应信号,在恶性进展过程中减少.
- MPNSTs表现出失调的生存和线粒体忠诚度途径.
- 针对CENPF和BIRC5抑制了MPNST的增长和生存能力.
- 靠近MPNST的神经纤维瘤显示了瘤和免疫监测程序的改变,这表明早期的分子事件在可见恶性瘤之前发生.
结论:
- 在PNST中确定了可能预测恶性转变风险的分子特征.
- 这些签名可以作为诊断工具来增强组织病理学.
- 促进PNF的NF1患者的风险适应护理.
更多相关视频
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.2K
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
2.0K
相关概念视频
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:26NF-kB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...